选择性纳米颗粒系统用于在炎症性肠病中药物输送
Alberta Ribeiro1, Rute Nunes1,2,3
1IUCS-University Institute of Health Sciences, Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), Rua Central de Gandra, 1317, 4585-116 Gandra, Portugal.
Pharmaceutics
|January 28, 2026
概括
纳米粒子系统为治疗炎症性肠病 (IBD) 提供了一种新的方法,通过专门针对胃肠道炎症区域的药物输送,提高疗效和减少副作用.
科学领域:
- 胃肠道学和免疫学
- 生物医学工程 生物医学工程
- 药物输送系统 药物输送系统
背景情况:
- 炎症性肠病 (IBD),包括性结肠炎 (UC) 和克罗恩病 (CD),涉及由于免疫系统缺陷和表皮屏障功能受损的慢性肠道炎症.
- 传统的IBD疗法受到系统性副作用,药物稳定性差以及缺乏部位特异性的限制.
- 纳米粒子 (NP) 系统为IBD治疗提供了一个有前途的替代方案,增强了针对性交付和治疗结果.
研究的目的:
- 审查设计用于针对性药物输送的新型纳米系统,用于炎症性肠病 (IBD).
- 探索IBD的病理生理变化如何利用在炎症的胃肠道中智能纳米粒子积累.
- 突出响应性NP的潜力,以提高药物疗效并最大限度地减少全身暴露.
主要方法:
- 对用于IBD治疗的纳米粒子系统现有文献的审查.
- 对IBD特异性特征 (如pH,酶,粘液) 的分析,这些特征会影响肠道内NP的行为.
- 新型纳米系统技术的概述,用于针对性地向炎症肠道区域输送.
主要成果:
- 纳米颗粒优先积聚在炎症结肠中,这是由于肠道的疾病特异性改变造成的.
- 与疾病相关的变化,如改变过渡时间,pH值,酶活性和粘液完整性等,可用于针对性地提供NP.
- 响应性纳米系统显示出增强药物输送和IBD治疗疗效的潜力.
结论:
- 基于纳米粒子的策略比常规治疗炎症性肠病具有显著的优势.
- 智能和灵敏的纳米系统可以被设计为针对肠道炎症区域,改善治疗结果.
- 有针对性的NP交付有望实现更有效,更安全的IBD管理,减少系统性副作用.
相关概念视频
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.0K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.0K
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
962
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
962
01:21Inflammatory Bowel Disease V: Surgical Management
493
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
493
01:29Inflammatory Bowel Disease IV: Pharmacological Management
579
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
579
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
681
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
681
01:16Drug Delivery: Overview
827
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
827